91´«Ã½ÔÚÏß

The ALS Research Center at 91´«Ã½ÔÚÏß and University Hospital of Northern Sweden, Region Västerbotten, was established in 1993 and the...

The focus of our research is the genetic causes of amyotrophic lateral sclerosis (ALS). The last decade has seen great advances in the field of...

Our lab works on integrating multi-omics datasets, machine learning, and large-scale mechanistic models to build clinically predictive computationa...

Ovarial cancer

Studies of the breakdown of fat in human plasma by lipoprotein lipase.

Vitamin D in bladdercancer.

Our aim is to increase the understanding of squamous cell carcinoma in the mobile tongue.

Methods for breaking cisplatin resistance in lung cancer treatment.

Plasmakllikrein, FXI, FXII and other factors of the hemostatic system

Telomere biology in blood cells and molecular factors - prognosis in lymphatic leukemias and lymphomas.

Metastatic cancer is usually associated with poor prognosis and survival for the patient. We are researching to develop new, better cancer drugs an...

The most important goal of our research is to understand the specific processes involved in hereditary diseases, especially neurological and...

Our group researches biofilms of bacteria.

ALS Research

Our group studies biomarkers for aggressive prostate cancer.

Colorectal cancer is a widespread disease, yearly affecting around 6000 individuals in Sweden.

Our group studies Whisper mutations.

We do research on epigenetics and telomere biology in hematological malignancies.

Since 1993 we have closely studied the biochemical properties of SOD1 and how it causes ALS. Our focus is on how mutations in SOD1 leads to...

Our research centers on the disease amyotrophic lateral sclerosis (ALS).

Regulation of mitochondrial metabolism and its importance for diabetes, other dysmetabolic states, and drug resistance.